Jagsonpal Pharma

Market Cap: Small Cap
Industry: Pharmaceuticals & Drugs
ISIN: INE048B01035
NSEID: JAGSNPHARM
BSEID: 507789

INR

214.00

12.1 (5.99%)

BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.22 lacs

Click here to access the older version

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Rs cr

Standalone Quarterly Results

Dec'24

Sep'24

Jun'24

Mar'24

Dec'23

Sep'23

Jun'23

Quarterly Analysis Highlights - QoQ

Net Sales

QoQ Growth in quarter ended Dec 2024 is -0.88% vs 21.57% in Sep 2024

Standalone Net Profit

QoQ Growth in quarter ended Dec 2024 is 179.14% vs 115.01% in Sep 2024

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Dec 2024 is -2.70% vs 58.98% in Sep 2024

Interest

QoQ Growth in quarter ended Dec 2024 is 13.04% vs 4.55% in Sep 2024

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

Compare Quarterly Results Of Jagsonpal Pharma With

Select Peers

Figures in Rs cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

74.03

2,396.57

-2,322.54

-96.91%

Other Operating Income

0.00

Total Operating income

74.03

2,396.57

-2,322.54

-96.91%

Raw Material Cost

5.27

179.72

-174.45

-97.07%

Purchase of Finished goods

21.12

445.60

-424.48

-95.26%

(Increase) / Decrease In Stocks

0.13

34.08

-33.95

-99.62%

Employee Cost

18.08

521.79

-503.71

-96.54%

Power Cost

0.00

Manufacturing Expenses

0.00

Selling and Distribution Expenses

0.00

Other Expenses

13.59

474.45

-460.86

-97.14%

Total Expenditure (Excl Depreciation)

58.19

1,655.64

-1,597.45

-96.49%

Operating Profit (PBDIT) excl Other Income

15.84

740.93

-725.09

-97.86%

Other Income

2.32

69.82

-67.50

-96.68%

Operating Profit (PBDIT)

18.16

810.75

-792.59

-97.76%

Interest

0.26

199.47

-199.21

-99.87%

Exceptional Items

23.18

0.00

23.18

Gross Profit (PBDT)

41.08

611.28

-570.20

-93.28%

Depreciation

2.41

87.03

-84.62

-97.23%

Profit Before Tax

38.67

524.25

-485.58

-92.62%

Tax

6.68

107.87

-101.19

-93.81%

Provisions and contingencies

0.00

Profit After Tax

31.99

416.38

-384.39

-92.32%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

31.99

416.38

-384.39

-92.32%

Equity Capital

13.23

40.06

-26.83

-66.97%

Face Value

2.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

1.93

10.39

-8.46

-81.42%

Diluted Earnings per share

1.90

10.33

-8.43

-81.61%

Operating Profit Margin (Excl OI)

21.40%

30.92%

0.00

-9.52%

Gross Profit Margin

55.49%

25.51%

0.00

29.98%

PAT Margin

43.21%

17.37%

0.00

25.84%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 74.03 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -0.88% vs 21.57% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 56.74% vs -21.47% in Dec 2023

Quarterly - Standalone Net Profit

Standalone Net Profit 31.99 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 179.14% vs 115.01% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 707.83% vs -49.17% in Dec 2023

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 15.84 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is -2.70% vs 58.98% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 367.26% vs -60.72% in Dec 2023

Quarterly - Interest

Interest 0.26 Cr

in Dec 2024

Figures in Rs Cr

QoQ Growth in quarter ended Dec 2024 is 13.04% vs 4.55% in Sep 2024

YoY Growth in quarter ended Dec 2024 is 13.04% vs 27.78% in Dec 2023

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 21.40%

in Dec 2024

Figures in Rs %

QoQ Growth in quarter ended Dec 2024 has fallen from Sep 2024

YoY Growth in quarter ended Dec 2024 has improved from Dec 2023